Added corticosteroid deemed ineffective for cancer pain

Added corticosteroid deemed ineffective for cancer pain

(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.

Ørnulf Paulsen, M.D., of the Telemark Hospital Trust in Skien, Norway, and colleagues randomly assigned 50 adult patients receiving opioids for cancer pain to either with MP or placebo (PL).

At day seven, the researchers observed no difference between the groups in pain intensity (MP, 3.60 versus PL, 3.68; P = 0.88) or relative analgesic consumption (MP, 1.19 versus PL, 1.20; P = 0.95). Patients receiving MP, compared with those receiving PL, experienced reduced fatigue (−17 versus 3 points; P = 0.003), decreased appetite loss (−24 versus 2 points; P = 0.003), and increased (5.4 versus 2.0 points; P = 0.001). No differences in adverse effects were observed between the groups.

"MP 32 mg daily did not provide additional analgesia in patients with cancer receiving opioids, but it improved fatigue, appetite loss, and patient satisfaction," the authors write. "Clinical benefit beyond a short-term effect must be examined in a future study."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Chiropractic care beats sham therapy for spinal pain

Nov 19, 2013

(HealthDay)—Short-term chiropractic therapy is more effective than a sham intervention for treating spinal pain, but the difference is not clinically meaningful, according to research published in the Nov. ...

Drinking coffee, smoking may protect against cholangitis

Jul 08, 2014

(HealthDay)—Coffee consumption and smoking might protect against the development of primary sclerosing cholangitis (PSC), according to a study published in the June issue of Clinical Gastroenterology an ...

Screening tool does not cut distress in cancer patients

Sep 07, 2013

(HealthDay)—Distress monitoring and needs assessment using the Distress Thermometer and Problem List (DT&PL) does not appear to be cost-effective in improving mood states in cancer patients, according to ...

Multimodal analgesia lessens post-op morphine needs

Aug 23, 2013

(HealthDay)—A multimodal analgesia combination appears to be safe and effective for pain relief after lumbar decompressive laminectomy, according to a study published in the August issue of the Journal of ...

Recommended for you

Generation of tanners see spike in deadly melanoma

5 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

5 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Cancer: Tumors absorb sugar for mobility

17 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

User comments